Insider Transactions in Q4 2021 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2021
|
Matthew Gall Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.73%
|
$230,000
$46.45 P/Share
|
|
Dec 22
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,163
-5.36%
|
$711,172
$44.8 P/Share
|
|
Dec 22
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,663
+2.04%
|
$6,652
$4.3 P/Share
|
|
Dec 21
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,226
-10.33%
|
$845,944
$44.61 P/Share
|
|
Dec 21
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,226
+16.48%
|
$76,904
$4.3 P/Share
|
|
Dec 20
2021
|
David Hallal |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$2,150,000
$43.57 P/Share
|
|
Dec 20
2021
|
David Hallal |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.75%
|
$150,000
$3.63 P/Share
|
|
Dec 20
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,111
-10.44%
|
$391,773
$43.94 P/Share
|
|
Dec 20
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,111
+9.45%
|
$36,444
$4.3 P/Share
|
|
Dec 17
2021
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$287,000
$41.0 P/Share
|
|
Dec 17
2021
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$28,000
$4.3 P/Share
|
|
Dec 10
2021
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$119,000
$34.5 P/Share
|
|
Dec 10
2021
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$14,000
$4.3 P/Share
|
|
Dec 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,456
-0.34%
|
$642,048
$33.63 P/Share
|
|
Dec 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,456
-0.34%
|
$642,048
$33.63 P/Share
|
|
Dec 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,558
-0.34%
|
$1,074,414
$33.63 P/Share
|
|
Dec 06
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,208
-0.09%
|
$336,864
$33.76 P/Share
|
|
Dec 06
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,208
-0.09%
|
$336,864
$33.76 P/Share
|
|
Dec 06
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,083
-0.09%
|
$563,739
$33.76 P/Share
|
|
Dec 03
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,167
-0.23%
|
$705,845
$35.46 P/Share
|
|
Dec 03
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,167
-0.23%
|
$705,845
$35.46 P/Share
|
|
Dec 03
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,749
-0.23%
|
$1,181,215
$35.46 P/Share
|
|
Dec 02
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,187
-0.63%
|
$1,264,358
$34.29 P/Share
|
|
Dec 02
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,187
-0.63%
|
$1,264,358
$34.29 P/Share
|
|
Dec 02
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
62,230
-0.64%
|
$2,115,820
$34.29 P/Share
|
|
Dec 01
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,395
-0.14%
|
$421,430
$34.59 P/Share
|
|
Dec 01
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,395
-0.14%
|
$421,430
$34.59 P/Share
|
|
Dec 01
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,742
-0.14%
|
$705,228
$34.59 P/Share
|
|
Nov 30
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,937
-0.56%
|
$1,153,858
$34.9 P/Share
|
|
Nov 30
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,937
-0.56%
|
$1,153,858
$34.9 P/Share
|
|
Nov 30
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
56,801
-0.57%
|
$1,931,234
$34.9 P/Share
|
|
Nov 29
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,371
-0.17%
|
$352,614
$34.91 P/Share
|
|
Nov 29
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,371
-0.17%
|
$352,614
$34.91 P/Share
|
|
Nov 29
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,356
-0.17%
|
$590,104
$34.91 P/Share
|
|
Nov 26
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,674
-0.21%
|
$443,590
$35.76 P/Share
|
|
Nov 26
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,674
-0.21%
|
$443,590
$35.76 P/Share
|
|
Nov 26
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,210
-0.21%
|
$742,350
$35.76 P/Share
|
|
Nov 24
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,337
-0.39%
|
$1,308,132
$36.09 P/Share
|
|
Nov 24
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,337
-0.39%
|
$1,308,132
$36.09 P/Share
|
|
Nov 24
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
60,808
-0.4%
|
$2,189,088
$36.09 P/Share
|
|
Nov 23
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,500
-15.64%
|
$522,000
$36.08 P/Share
|
|
Nov 23
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,004
-0.32%
|
$720,144
$36.36 P/Share
|
|
Nov 23
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,004
-0.32%
|
$720,144
$36.36 P/Share
|
|
Nov 23
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,476
-0.33%
|
$1,205,136
$36.36 P/Share
|
|
Nov 22
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,263
+14.93%
|
$195,156
$12.45 P/Share
|
|
Nov 22
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,114
-0.34%
|
$781,218
$37.49 P/Share
|
|
Nov 22
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,114
-0.34%
|
$781,218
$37.49 P/Share
|
|
Nov 22
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,333
-0.35%
|
$1,307,321
$37.49 P/Share
|
|
Nov 18
2021
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,000
-100.0%
|
$952,000
$34.5 P/Share
|
|
Nov 18
2021
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+50.0%
|
$112,000
$4.3 P/Share
|